Phil Bilodeau, MD
1.3K posts

Phil Bilodeau, MD
@phil_bilodeau
Neuroimmunology 🧠 🔥 clinician scientist @MGHNeurology, @BWHNeurology. Grad of @harvardneuroMDs & @mcgillmed.





Controversial neurology opinion of the day: the weird obsession we have of presenting the patient’s handedness as super important (“this 57 right-handed male…” etc) is almost never of any real clinical value. (Don’t hate me cognitive people!)

Good thing this patient from this 2016 publication has 4 optic nerves.





Math question: Which line(s) are not responsible for increasing costs in healthcare. Hint: I took old math.

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks jnnp.bmj.com/content/early/… @NeuroVisionLab





How will anti-amyloid immunotherapies and ARIA affect stroke care? @phil_bilodeau, John Dickson, and I review the latest data on ARIA in the context of acute stroke care and secondary stroke prevention here: secure-web.cisco.com/1xmfXF0oNepoSs…


1/ A 34 yo M presents with worsening confusion and seizures. He is febrile. He is intubated and transferred to the NeuroICU. A #continuumcase about a cause that’s probably low (not) on your DDx.


Introductory biology cannot teach you what “cannot” happen because it is introductory, not comprehensive. Even scientific research cannot do that, but this statement is completely false and falsifiable by reading reputable scientific literature.

